Biologic therapies for severe asthma: Real life experience & Patient selection
Speaker: Gert-Jan Braunstahl
Gert-Jan Braunstahl is a pulmonologist working in a tertiary severe asthma center in Rotterdam. His scientific work has significantly contributed to the “united airways” concept. After this the focus has shifted towards clinical application of fractionated nitric oxide (FeNO) in respiratory allergy. Nowadays, he is involved in several lines of research, such as morbid obesity and asthma, aging of the asthmatic lung, bacterial lysates and prevention of asthma exacerbations, and several clinical studies investigating biologicals in asthma. He holds a position as an associate professor at Erasmus MC and currently he is the head of the section Asthma and Allergy of the Dutch Association of Chest Physicians. In this webinar, Dr Braunstahl will speak about biologic therapies for severe asthma. He will present key RWE data, share real life experience and how to use it for patient selection.
This webinar is intended for pulmonoligists, ENT and pediatricians and is organized by Sanofi North Europe. Sanofi pro-cesses personal data in accordance with the GDPR. The event will be reported to ENLI prior to the event.
Dette arrangementet arrangeres i samsvar med avtaler om samhandling som Legemiddelindustri-foreningen har inngått med Den norske legeforening, Norges Farmaceutiske Forening, Norsk Sykepleierforbund og De regionale helseforetakene. For mer informasjon se https://www.lmi.no/lmi/fagomra- der/lover-og-regler/ samarbeidsavtaler/. Sanofi behandler personopplysninger i henhold til GDPR.
For privatpraktiserende helsepersonell kan legemiddelfirmaet dekke reise- og oppholdskostnaden knyttet til arrangementet.
Deltager ansatt i helseforetak/Deltagers arbeidsgiver (helseforetak): Den ansatte er selv ansvarlig for å innhente tillatelse fra arbeidsgiver for å delta på møtet. Ansatte i helseforetak må selv/arbeidsgiver dekke reise og oppholdskostnader.
